- Home
- WLK vs ELAN Comparison
WLK vs ELAN Comparison
Compare WLK & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLK | ELAN |
|---|---|---|
| Founded | 1986 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 12.7B |
| IPO Year | 2004 | 2018 |
Fundamental Metrics
Financial Performance| Metric | WLK | ELAN |
|---|---|---|
| Price | $112.33 | $22.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $106.87 | $27.89 |
| AVG Volume (30 Days) | 1.0M | ★ 4.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,170,000,000.00 | $4,715,000,000.00 |
| Revenue This Year | $5.51 | $8.21 |
| Revenue Next Year | $3.74 | $5.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $56.33 | $9.26 |
| 52 Week High | $124.23 | $27.72 |
Technical Indicators
Market Signals| Indicator | WLK | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 47.66 | 39.87 |
| Support Level | $105.48 | $22.17 |
| Resistance Level | $116.46 | $23.16 |
| Average True Range (ATR) | 4.36 | 0.82 |
| MACD | -1.24 | -0.08 |
| Stochastic Oscillator | 14.56 | 19.70 |
Price Performance
Historical ComparisonAbout WLK Westlake Corporation
Westlake Corp is a vertically integrated international manufacturer and marketer of both housing and infrastructure products and performance and essential materials that are designed to enhance the lives of people every day. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and international compounds businesses.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.